NCT02985632View on ClinicalTrials.gov

A Study to Evaluate the Pharmacokinetics of BMS-986141 in Participants With Hepatic Impairment Compared to Healthy Participants

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

January 11, 2017

Primary Completion Date

May 18, 2017

Study Completion Date

July 7, 2017

Conditions
Hepatic Impairment
Interventions
DRUG

BMS-986141

Trial Locations (3)

32809

Clinical Research Center, Orlando

33014

Clinical Pharmacology of Miami, Miami

78215

Texas Liver Institute, San Antonio

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY